Małgorzata Pieniążek

4PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland.

|Sep 27, 2025
Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis.

Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Manuela Las-Jankowska

|Aug 22, 2025
Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort.

Małgorzata Pienia̧żek, Anna Polakiewicz-Gilowska, Manuela Las-Jankowska

|Nov 27, 2024
Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer.

Mirosława Püsküllüoğlu, Marek Ziobro, Małgorzata Pieniążek

Pageof 1

Frequent Collaborators

3 joint publications

Mirosława Püsküllüoğlu

1 joint publications

Marek Ziobro

1 joint publications

Renata Pacholczak-Madej

1 joint publications

Aleksandra Grela-Wojewoda